Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids

Laboratory Investigation

Volumn 80, Issue 4, 2000, Pages 443-454

  Hornig, Carsten ^a   Barleon, Bernhard ^b   Ahmad, Shakil ^c   Vuorela, Piia ^d   Ahmed, Asif ^c   Weich, Herbert A ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b TUMOR BIOLOGY CENTER   (Germany)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; MEMBRANE RECEPTOR; TYROSINE KINASE RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

AMNION FLUID; ANGIOGENESIS; ARTICLE; BODY FLUID; COMPLEX FORMATION; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRAUTERINE GROWTH RETARDATION; LIGAND BINDING; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN SECRETION; RNA SPLICING; SIGNAL TRANSDUCTION;

EID: 0034007818     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780050     Document Type: Article

References (41)

1. Ahmed A and Kilby MD (1997). Placental insufficiency: Hypoxia or hyperoxia? Lancet 350:826-827.
2. Ahmed A, Dunk C, Kniss D, and Wilkes M (1997). Role of VEGFR-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells. Lab Invest 76:779-791.
3. Anthony FW, Evans PW, Wheeler T, and Wood PJ (1997). Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins. Ann Clin Biochem 34:276-280.
4. Banks RE, Forbes MA, Searles J, Pappin D, Canas B, Rahman D, Kaufmann S, Walters CE, Jackson A, Eves P, Linton G, Keen J, Walker JJ, and Selby PJ (1998). Evidence for the existence of a novel pregnancy associated soluble variant of the vascular endothelial growth factor receptor, Flt-1. Mol Hum Reprod 4:377-386.
5. Barleon B, Hauser S, Schöllmann C, Weindel K, Marmè D, Yayon A, and Weich HA (1994). Differential expression of the two VEGF receptors fit and KDR in placenta and vascular endothelial cells. J Cell Biochem 54:56-66.
6. Barleon B, Totzke F, Herzog C, Blanke S, Kremmer E, Siemeister G, Marmè D, and Martiny-Baron G (1997). Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1. J Biol Chem 272:10382-10388.
7. Boocock CA, Charnock-Jones DS, Sharkey AM, McLaren J, Barker PJ, Wright KA, Twentyman PR, and Smith SK (1995). Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J Natl Cancer Inst 87:506-516.
8. Clark DE and Charnock-Jones DS (1999). Placental angiogenesis: The role of the VEGF family of proteins. Angiogenesis 2:309-318.
9. Carter AM (1989). Factors affecting gas transfer across the placenta and the oxygen supply to the fetus. J Dev Physiol 12:305-322.
10. Clauss M (1998). Functions of the VEGFR-1 (FLT-1) in the vasculature. Trends Cardiovasc Med 8:241-245.
11. Donnini S, Machein MR, Plate KH, and Weich HA (1999). Expression and localization of placenta growth factor and PIGF receptors in human meningiomas. J Pathol 189:66-71.
12. Ferrara N and Davis-Smyth T (1997). The biology of vascular endothelial growth factor. Endocrinol Rev 18:4-25.
13. Fiebich BL, Jäger B, Schöllmann C, Weindel K, Wilting J, Kochs G, Marmè D, Hug H, and Weich HA (1993). Synthesis and assembly of functionally active human vascular endothelial growth factor homodimers in insect cells. European J Biochem 211:19-26.
14. Flamme I, Frölich T, and Risau W (1997). Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J Cell Physiol 173:206-210.
15. Fong GH, Rassant J, Gertenstein M, and Breitman M (1995). Role of Flt-1 receptor tyrosine kinase in regulation of assembly of vascular endothelium. Nature 376:66-67.
16. Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, Kavanaugh D, and Carbone DP (1996). Production of vascular endothelial growth factor by human tumours inhibits the functional maturation of dendritic cells. Nat Med 2:1096-1103.
17. Gerber HP, Condorelli F, Park J, and Ferrara N (1997). Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. J Biol Chem 272: 23659-23667.
18. Hauser S and Weich HA (1993). A heparin-binding form of placenta growth factor (PIGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors 9:259-268.
19. He Y, Smith SK, Day KA, Clark DE, Licence DR, and Charnock-Jones DS (1999). Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (Flt-1) pre-mRNA is important for the regulation of VEGF activity. Mol Endocr 13:537-545.
20. Hiratsuka S, Minowa O, Kuno J, Noda T, and Shibuya M (1998). Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci USA 95:9349-9354.
21. Hornig C, Behn T, Bartsch W, Yayon A, and Weich HA (1999). Detection and quantification of complexed and free soluble human vascular endothelial growth factor receptor-1 (sVEGFR-1) by ELISA. J Immunol Meth 226:169-177.
22. Kendall RL and Thomas KA (1993). Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 90: 10705-10709.
23. Kendall RL, Wang G, and Thomas KA (1996). Identification of a natural soluble form of the vascular endothelial growth factor receptor FLT-1 and its heterodimerization with KDR. Biochem Biophys Res Commun 226:324-328.
24. Khaliq A, Dunk CE, Shams M, Li XF, Whittle MJ, Weich H, and Ahmed A (1999). Hypoxia down-regulates placenta growth factor whereas fetal growth restriction up-regulates placenta growth factor expression: Molecular evidence for placental hyperoxia in intrauterine growth restriction. Lab Invest 79:151-170.
25. Kondo K, Hiratsuka S, Subbalakshmi E, Matsushime H, and Shibuya M (1998). Genomic organization of the flt-1 gene encoding for vascular endothelial growth factor (VEGF) receptor-1 suggests an intimate evolutionary relationship between the 7-lg and the 5-lg tyrosine kinase receptors. Gene 208:297-305.
26. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, and Ferrara N (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309.
27. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radcziejewski C, Compton D, McLain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, and Yancopoulos GD (1997). Angiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesis. Science 277:55-60.
28. Olofsson B, Korpelainen E, Pepper MS, Mandriota SJ, Aase K, Kumar V, Gunji Y, Jeltsch MM, Shibuya M, Alitalo K, and Eriksson U (1998). Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc Natl Acad Sci USA 95:11709-11714.
29. Pajusola K, Aprelikova O, Korhonen J, Kaipainen A, Pertovaara L, Alitalo R, and Alitalo K (1992). FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res 52:5738-5743.
30. Park JE, Chen HH, Winer J, Houck KA, and Ferrara N (1994). Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 269: 25646-25654.
31. Röckl W, Hecht D, Sztajer H, Waltenberger J, Yayon A, and Weich HA (1998). Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2. Exp Cell Res 241:161-170.
32. nd edition. Cold Spring Harbour Laboratory, New York.
33. Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, and Shibuya M (1995). A unique signal transduction pathway for the FLT tyrosine kinase, a receptor for vascular endothelial growth factor. Oncogene 10:135-147.
34. Shalabi F, Rossant J, Yamaguchi TP, Gertenstein M, Wu XF, Breitman ML, and Shuh AC (1995). Failure of blood island formation and vasculogenesis in Flk-1 deficient mice. Nature 376:62-66.
35. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H, and Sato M (1990). Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5:519-524.
36. Shweiki D, Itin A, Soffer D, and Keshet E (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845.
37. Terman B, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, and Bohlen P (1992). Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 187:1579-1586.
38. Terman BI, Khandke L, Dougher-Vermazan M, Maglione D, Lassam NJ, Gospodarowicz D, Persico MG, Bohlen P, and Eisinger M (1994). VEGF receptor subtypes KDR and Flt-1 show different sensitivities to heparin and placenta growth factor. Growth Factors 11:187-195.
39. Vuorela-Vepsäläinen P, Alfthan H, Orpana A, Alitalo K, Stenman UH, and Halmesmäki E (1998). Vascular endothelial growth factor is bound in amniotic fluid and maternal serum. Hum Reprod 14:1346-1351.
40. Wang D, Huang HJS, Kazlauskas A, and Cavenee WK (1999). Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase. Cancer Res 59:1464-1472.
41. Weindel K, Marmé D, and Weich HA (1992). Aids-associated Kaposis sarcoma cells in culture express vascular endothelial growth factor. Biochem Biophys Res Commun 183:1167-1174.